Search

everythinglearnresearchcommunity

for

Search:↓

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Lichen planus is a chronic autoimmune disease that is hard to treat and more common in women.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

Targeting immune pathways like JAK/STAT may help treat frontal fibrosing alopecia.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

Alopecia areata patients have fewer protective regulatory B cells, which may contribute to the disease.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Different types of skin cells and immune cells play a role in healing UV-damaged skin, with chronic UV exposure causing lasting damage to certain skin cells.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

The document concludes that the immune-inhibitory environment of the hair follicle may prevent melanoma development.

An 8-year-old girl developed a rare skin condition in a linear pattern on one side of her body after a lung infection, which improved with treatment.

Mouse hair follicle stem cells can help prevent Type 1 Diabetes.

Different types of sun exposure damage skin cells and immune cells, with chronic exposure leading to more severe and lasting damage.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Lichen planopilaris may be an autoimmune disease causing hair loss due to immune system issues in hair follicles.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

ILC1 cells contribute to hair loss in alopecia areata.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

Alopecia areata is an autoimmune disease affecting hair follicles and may harm heart health.

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.

Systemic corticosteroids can help treat rapidly spreading vitiligo but require more research for safer use.

Some treatments for autoimmune hair loss work, but JAK inhibitors like tofacitinib are promising for regrowth.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Alopecia areata involves specific gene changes and immune pathways, offering new treatment targets.